Introduction
Dendritic cells (DC) are highly specialized, professional APC that initiate and regulate immune responses via their interaction with Ag-specific T-cells. 1, 2 After organ transplantation, donor-derived DC migrate to T-cell areas of secondary lymphoid tissue, 3 where they present MHC Ags to host T-cells via direct allorecognition. High levels of MHC and costimulatory molecules on mature DC allow these cells to function as potent APC, and they have long been regarded as the principal instigators of rejection. 3, 4 By contrast, immature donor-derived DC deficient in surface costimulatory molecules, and that resemble DC freshly isolated from commonly transplanted organs, can induce alloAg-specific T-cell anergy in vitro. 5 These DC also prolong the survival of fully allogeneic grafts in rodents, 6, 7 -in some cases indefinitely. 8 There is also evidence that immature human DC can induce allogeneic T regulatory cells in vitro 9 and promote Ag-specific T-cell tolerance in healthy volunteers. 10 Thus, DC offer potential for therapy of graft rejection and the promotion of transplant tolerance. 11, 12 An attractive conceptual approach to the enhancement of DC tolerogenicity is their genetic modification to express genes encoding immunosuppressive molecules. 13 Delivery of these molecules by DC to the precise microenvironment in which T-cell responses are instigated minimizes systemic levels of the transgene product. Recently, murine or human DC have been transduced with viral or non-viral vectors to express either IL-10, 14, 15 cytotoxic T lymphocyte Ag-4 (CTLA4) Ig, 16, 17 Fas Ligand (CD95L) 18, 19 or TGFb1, 20 that suppress T-cell responses by various mechanisms. These strategies have clearly demonstrated the capacity of genetically engineered DC to inhibit allogeneic T-cell responses, both in vitro and in vivo. However, there have been few reports that these DC can induce long-term organ allograft survival. 19, 21, 22 IL-4 is a Th2 cell-derived cytokine that inhibits IL-2 and IFNg production by Th1 cells, promotes Th2 cell differentiation, and inhibits proinflammatory cytokine (IL-4, IL-6, IL-8 and TNFa) production by monocytes/ macrophages. 23 Several studies that have investigated the role of IL-4 in allograft rejection, either by systemic administration of rIL-4, [24] [25] [26] use of IL-4 knockout or transgenic mice, 27 or IL-4 gene transfer to the graft, 28 suggest that IL-4 functions to prolong transplant survival. On the other hand, administration of soluble IL-4R delays heart allograft rejection, 29 whereas IL-4-deficient mice can reject allografts with the same vigor as wildtype recipients, and develop the same extent of obliterative vasculopathy as those transplanted to wild-type counterparts. 30 Recently, two independent reports have shown that a single systemic injection of myeloid DC genetically engineered to express IL-4 is highly effective as prophylactic treatment or therapy of experimental autoimmune arthritis. 31, 32 In view of these striking observations and the absence of information concerning IL-4-transduced DC and alloimmune responses, we examined the impact of IL-4 gene delivery to myeloid DC on T-cell alloreactivity and organ allograft survival. The findings reveal that ectopic expression of IL-4 by DC is associated with enhanced T-cell allostimulatory activity linked to increased bioactive IL-12p70 production following CD40 ligation, and with exacerbation of vascularized allograft rejection.
Results
Ad transduction results in increased expression of surface MHC class II and costimulatory molecules Myeloid DC were propagated from B10 BM cells in GM-CSF and IL-4, as described in the Materials and methods section and harvested on day 5 of culture. The purity of immunobead-sorted CD11c + DC ranged from 88% to 95%. The DC were transduced with adenoviral (Ad) vectors encoding IL-4 cDNA(Ad-IL-4) or control neomycin-resistance gene (Ad-Neo) at 50 multiplicity of adenoviral (MOI) and maintained for a further 24 h in culture. Gene transduction efficiency, determined by expression of enhanced green fluorescent protein (EGFP) by Ad-EGFP-transduced DC, ranged from 44% to 52%. The immunophenotype of pre-and post-transduced DC was compared by mAb staining and flow cytometric analysis. As shown in Table 1 and in keeping with our previous observations, 33 the expression of MHC class II and costimulatory molecules was upregulated by Ad transduction alone. There was no significant difference in the level of expression of these key surface Ags between the control gene (Ad-Neo) and Ad-IL-4-transduced DC.
Ad-IL-4-transduced DC secrete the transgene product
To confirm secretion of IL-4 by Ad-IL-4-transduced DC, 2 Â 10 5 transduced cells were cultured in 24-well plates and culture supernatants collected on days 1, 2 and 3 after transduction for measurement of IL-4 by ELISA (Figure 1 ). Ad-IL-4-transduced DC produced IL-4 within 1 day of transduction. Levels of secreted IL-4 continued to rise during the following 24 h. Maximal concentrations of IL-4, achieved within 2-3 days of culture, were 50-60 ng/ml. No IL-4 was detected in supernatants of AdNeo-transduced DC.
Ad-IL-4-transduced DC secrete markedly increased amounts of IL-12p70 in response to LPS stimulation, CD40 ligation or allogeneic T-cells
To ascertain the capacity of transduced or non-transduced DC to produce bioactive IL-12p70, a strong inducer of Th1 responses, DC were cultured with or without LPS (2 mg/ml) or anti-CD40 mAb (10 mg/ ml) for 24 h. Without stimulation, neither non-transduced nor Ad-Neo-transduced DC secreted IL-12p70 above the detection limit. By contrast, Ad-IL-4-transduced DC secreted low levels of IL-12p70. After LPS stimulation, low IL-12p70 production was detected by To determine IL-12p70 production following interaction of non-transduced, Ad-Neo-transduced, or Ad-IL-4-transduced DC with naïve allogeneic T-cells, co-cultures of B10 DC and purified splenic C3H T-cells were established with or without anti-CD40L (10 mg/ml) to block CD40-CD40L ligation. Twenty-four hours later, culture supernatants were collected and IL-12p70 measured, as described in the Materials and methods section. In these MLR cultures, only Ad-IL-4-transduced DC secreted detectable IL-12p70. Production of the cytokine was unaffected by the presence of anti-CD40L mAb ( Figure 3 ).
Ad-IL-4-transduced DC enhance T-cell proliferation
We next examined the influence of Ad-Neo (control) or Ad-IL-4-transduced DC on naive allogeneic T-cell proliferation (primary MLR). Figure 4 shows that Ad-IL-4-transduced B10 DC induced markedly higher levels of C3H T-cell cultures of restimulated T-cells from Ad-Neo-transduced DC-treated mice, and a further significant increase was evident in those from Ad-IL-4-DC-treated animals (Po0.05). A similar gradation in IFNg-production was found in culture supernatants collected at an earlier time point (24 h). Thus, concentrations of IFNgin cultures of restimulated T-cells from control and AdNeo-and Ad-IL-4-DC-treated mice were 2.96 7 0.36, 4.91 7 0.92, and 6.61 7 0.53 ng/ml, respectively, at 24 h. Notably, both IL-4 and IL-10 production was increased strikingly in cultures of restimulated T-cells from mice given Ad-IL-4 DC compared with Ad-Neo-DC-treated controls. No IL-4 was detected in control cultures; IL-10 was also not detected in cultures containing T-cells from the control (non-treatment) group (Figures 6a-d) .
T-cells from mice primed with Ad-IL-4-transduced DC exhibit increased ex vivo anti-donor CTL activity
We also examined anti-donor CTL and NK cell activities mediated by splenic lymphocytes from mice injected systemically with Ad-IL-4-transduced or Ad-Neo-DC. As shown in Figures 7a and b, a modest but statistically significant (P o0.05) increase in anti-donor-specific CTL activity was observed in the Ad-IL-4-transduced DC group. No influence of IL-4 transduction on NK cell activity in mice given allogeneic DC was observed (Figure 7c ). To test their influence on organ allograft survival, 10 6 Ad-IL-4-transduced or control Ad-Neo-transduced B10 DC were injected i.v. , 7 days before B10 heart transplantation in C3H recipients. Since anti-CD40L mAb has been shown to markedly prolong heart graft survival in mice given either immature or mature donor myeloid DC, 34, 35 groups of mice also received Ad-IL-4-or Ad-Neotransduced control DC in combination with the mAb (MR1). As shown in Figure 8a , Ad-IL-4-transduced DC accelerated graft rejection significantly (Po0.05). Moreover, whereas anti-CD40L mAb alone prolonged heart transplant survival from 11 to 21 days, this effect was abrogated by Ad-IL-4-transduced DC. Interestingly, a significant greater than additive effect of Ad-Neocontrol-DC and anti-CD40L mAb on prolongation of graft survival was observed (Figure 8b ).
Discussion
In this study, we have confirmed that Ad delivery of IL-4, a major Th2-driving cytokine, to murine BM-derived myeloid DC results in high transduction efficiency and secretion of the transgene product. Like control gene (Ad-Neo)-transduced DC, these Ad-IL-4-transduced DC 
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K Kaneko et al organ allograft rejection and negated the therapeutic effect of the costimulation blocking agent anti-CD40L mAb. These effects contrast markedly with the ability of donor DC expressing other transgenic anti-inflammatory/immunosuppressive molecules to inhibit alloimmune reactivity [15] [16] [17] and with the recently reported striking therapeutic effect of autologous Ad-IL-4-transduced DC in murine collagen-induced arthritis. 31 In the latter study, similar amounts of IL-4 were secreted in vitro by the genetically modified DC to those observed in the present investigation.
Reports concerning the influence of IL-4 on alloimmune reactivity have been rather inconsistent. Several studies have suggested an inhibitory role of IL-4 in alloimmune reactivity and host responses to organ grafts. Thus, there is evidence that systemic IL-4 administration markedly prolongs allogeneic neonatal rat heart graft survival, 25 and that intragraft infusion of IL-4 also inhibits heart graft rejection. 24 Combination of rIL-4 and cyclosporine A extends cardiac allograft survival in rats and syngenic pancreatic islet grafts in non-obese diabetic mice. 26 Moreover, Takeuchi et al 27 demonstrated that murine IL-4 transgenic heart allografts survived longer compared to wild-type hearts with downregulation of intragraft IL-2, whereas Kato et al 28 reported that Ad-IL-4 promoted long-term rat renal allograft survival. On the other hand, there are reports of no difference in heart graft survival in IL-4 knockout mice, 30 that IL-4 treatment fails to affect the survival of syngenic pancreatic islet grafts, 26 and that direct injection of Ad-IL-4 does not prolong rat cardiac allograft survival. 36 Although these findings are not all consistent, they suggest an overall propensity for IL-4 to negatively regulate alloimmune reactivity.
Previous reports on the influence of IL-4 on DC function, particularly in relation to its effect on IL-12 production, provides insight into the mechanistic basis of the enhancement of T-cell alloreactivity by Ad-IL-4-transduced DC. IL-4 plays a major role in priming Th0 cells to Th2 differentiation during the interaction of naïve T-cells and DC. 37, 38 Recently, however, IL-4 has also been shown to provide negative feedback that causes DC to produce the major Th1-inducing cytokine, bioactive IL12p70. IL-4 alone, or together with GM-CSF or IFNg, effectively enhances the production of the IL-12 heterodimer (p70) and in contrast to IFNg, selectively reduces production of the antagonistic homodimer inactive IL-12 p40 by mouse and human DC.
39 CD40 stimulation plays a dominant role in IL-12p70 secretion from DC. Thus, CD40 ligation of macrophages or monocyte-derived DC in the presence of IL-4 results in increased IL-12p70 production, an effect that is further enhanced by IFNg. 40 Further, stimulation of monocytes through CD40 triggering in the presence of IL-4 and IL-13 enhances IL-12p70 production, especially in the presence of IFNg. 41 In addition, Schulz et al 42 reported that CD40 triggering of IL-12p70 production by DC in vivo required a microbial priming signal. These observations suggest that in vivo, the capacity of IL-4 to enhance IL-12p70 production could potentially promote switching of a Th2 towards a Th1 response and support a dominant effect of CD40-CD40L interaction on Th1 development, even in the presence of Th2 cytokines. Ad transduction itself however induces the expression of IL-12p70 in Ad-IL-4 DC, both IL-12p35 and IL-12p40 appear to be upregulated. 33 As observed herein, after CD40 stimulation in vitro, Ad-IL-4 DC secreted greater amounts of IL-12p70 than AdNeo DC or non-transduced DC (Figure 2) . To determine the role of CD40L-CD40 ligation between T-cells and transduced or non-transduced DC, we cultured the DC with naive allogeneic T-cells. Only Ad-IL-4-transduced DC secreted IL-12p70 upon culture with T-cells. Addition of anti-CD40L mAb did not alter the level of secretion. This suggested that IL-12p70 secretion by Ad-IL-4-transduced DC was not dependent on CD40L-CD40 interaction in vitro.
Recently, Ad-or retrovirally transduced DC expressing IL-4 have been shown to profoundly inhibit murine collagen-induced arthritis, associated with Th2 skewing and specific Ab class switch. 31, 32 In this model, specific Ag is presented on autologous APC only. In the present report, donor-specific Ag (MHC) is first presented by donor-derived DC, then later by recipient APC after donor cell-delivered Ag has been processed by these latter cells. The treatment regimens with IL-4-transduced DC also differ between the collagen-induced arthritis and transplant models. In our study, the Ad-transduced DC were injected 7 days before transplantation, whereas in the arthritis model, Ad-IL-4 DC were injected after the mice were immunized with collagen. Thus, both the nature and kinetics of Ag-specific T-cell responses are IL-4-transduced DC accelerate graft rejection K Kaneko et al different. Interestingly, when we injected Ad-IL-4 DC 4 days after transplantation, there were no significant differences between the non-treated, Ad-Neo-DC-treated, and Ad-IL-4-DC-treated groups (data not shown).
Following their i.v. injection, Ad-infected DC traffic to the liver, spleen, and lymph nodes within 6 h but are not readily detected in other tissues. A similar pattern of distribution is observed at 24 h with relatively high numbers of injected DC evident in the lymph nodes. 31 Interestingly, serum levels of IL-4 after Ad-IL-4 DC administration are not significantly above normal background. 31 Thus, the immunomodulatory effect of the infused Ad-IL-4-transduced DC cannot be ascribed simply to elevated systemic levels of IL-4 but are more likely due to local effects of the genetically modified DC on immune function. Similarly, we have observed no evidence of elevated serum IL-12-p70 levels following Ad-IL-4 DC administration (unpublished observations), again suggesting that local influences of the transgene product are predominantly responsible for the observed effects on immune reactivity.
Another Th2 cytokine, IL-10, inhibits the synthesis of Th1 cytokines (IL-2 and IFNg) and suppresses both Tcell proliferative and cytolytic responses. Lee et al Generation, purification and stimulation of bone marrow (BM)-derived DC BM-derived DC were propagated as described 15, 45 with some modifications. Briefly, BM cells were harvested from femurs and tibias of normal B10 mice. Erythrocytes were lysed with 0.83%w/v NH 4 Cl buffer, and leukocytes depleted with a mAb cocktail consisting of rat IgG anti-B220, anti-Lyt 2 (2.43) anti-L3T4 (GK1.5) (all generated from hybridomas provided by the American Type Culture Collection [ATCC], Rockville, MD,USA) and anti-mouse Gr-1 mAbs (BD PharMingen, San Diego, CA,USA) plus rabbit complement (American Chemical and Scientific Corp., Westbury, NY,USA) on day 0. The cells were then cultured overnight (18 h) in RPMI-1640 (Life Technologies, Gaithersburg, MD,USA) supplemented with 10%v/v FBS, 50 mM 2-ME, 2 mM glutamine, 0.1 mM non-essential amino acids, 100 mg/ml streptomycin and 100 IU/ml penicillin (complete medium). On day 1, non-adherent cells were removed carefully by gentle pipetting, and fresh media containing r mouse (m) GM-CSF (1000 units [U]/ml) and r mIL-4 (1000 U/ml) was added. Non-adherent cells were harvested for Ad transduction on day 5, and CD11c + cells sorted after labeling with immunobead-conjugated anti-mouse CD11c mAb (Miltenyi Biotec, Auburn, CA,USA) followed by passage through a positive selection paramagnetic column (Miltenyi Biotec). The purity of the immunobead-sorted DC used in these experiments was consistently 90-97%. For some experiments, DC were stimulated with either LPS (Sigma, St. Louis, MO,USA; 2 mg/ml) or IgM anti-CD40 mAb (clone HM40-3; BD PharMingen, San Diego, CA,USA; 10 mg/ml).
Ad vectors and transduction of DC
rAd vectors were constructed, propagated and titered according to standard protocols, as described. 46 Briefly, vectors were generated by homologous recombination in 293 cells expressing Cre recombinase (CRE8 cells), following co-transfection of cDNA, an Ad5-derived, E1-and E3-deleted Ad backbone (psi 5), and pAd-lox, the Ad shuttle vector. The inserted cDNA sequences were expressed under the transcriptional control of the human CMV promoter. The rAd vectors were purified over two consecutive CsCl gradient ultracentrifugations, dialyzed at 4 o C against sterile buffer, aliquoted, and stored at -80 o C until use. rAd were titrated on CRE8 cells for PFUs. Washed, immunobead-sorted CD11c + DC (2-5 Â 10 6 ) were cultured with Ad vector at an MOI of 50 for 1 h, then incubated in complete medium in 6-well plates for a further 24 h.
Flow cytometry
Immunobead-sorted DC were characterized by flow cytometric analysis of cell surface Ag expression, as described. 5 Briefly, cells were stained with directly conjugated mAbs that recognized MHC class I (H2K b ), MHC class II (IA b ), CD40, CD80, CD86, or appropriate isotype-matched Igs (all from BD PharMingen). After staining (30 min; 4 o C) the cells were fixed with 1% (w/v) paraformaldehyde and analyzed using a Coulter EPICS XL.MCL (Beckman Coulter) flow cytometer and EXPO 32 software (Applied Cytometry Systems, Sheffield, UK).
MLR
The allostimulatory activity of DC for naïve T lymphocytes was determined in primary MLR. C3H splenic T-cells were purified by passage through nylon wool columns (30 
CTL assay
T-cells were prepared as described above and cultured with g-irradiated bulk splenocytes at 1:1 ratio for 5 days. Harvested cells were used as cytotoxic effectors, as described 6 . Briefly, EL4 lymphoma (H2 b ) and YAC1 cell lines purchased from the ATTC were used as targets. Ten million cells were labeled with 100 mCi of Na 2 51 CrO 4 . The percentage of specific 51 Cr release was determined after incubating effector and target cells at various ratios for 4 h at 37 o C in complete medium in 5% CO 2 in air. Maximum 51 Cr release was determined by osmotic lysis of the target cells. The percent-specific cytotoxicity was calculated using the following formula: % cytotoxicity ¼ 100 Â (experimental cpm -spontaneous cpm/ maximum cpm -spontaneous cpm).
Cytokine quantitation
Levels of IL-4, IL-10 and IFNg in culture supernatants were determined by ELISA using reagents purchased from BD PharMingen, and following the recommended procedures. The limit of sensitivity for detection of each cytokine was 19 pg/ml (IL-4), 9.8 pg/ml (IL-10) and 19 pg/ml (IFNg), respectively. Bioactive IL-12p70 was measured in culture supernatants and serum by Quantikine s M mouse IL-12p70 ELISA kit (R&D Systems Inc., Minneapolis, MN,USA) with a detection limit of 2.5 pg/ml.
Vascularized heart transplantation
Heterotopic (intra-abdominal) heart transplantation was performed from B10 to C3H mice as described. 47 Animals received either no treatment or were injected i.v. with 10 6 donor-derived DC (day -7) or with 125 mg anti-CD40L mAb (MR1; Bioexpress, Lebanon, NH,USA) i.p. 7, 4 and 0 days before transplantation, and 3 days after transplantation or with a combination of DC and the mAb. Graft survival was assessed by daily transabdominal palpation. Rejection was defined by the complete cessation of heartbeat.
Statistical analysis
Statistical comparisons were performed using the unpaired Student's 't' test. Graft survival curves were calculated by the Kaplan-Meier method and differences between groups were compared by the log-rank test. A 'P' value of o 0.05 was regarded as significant.
